China has already approved nearly thrice the number of innovative drugs than in the 13th five-year plan, Shanghai forum hears.
China’s new drug approvals take market scale beyond US$13 billion as innovation picks up
China has already approved nearly thrice the number of innovative drugs than in the 13th five-year plan, Shanghai forum hears.
